Jon Read

3.7k total citations
40 papers, 2.1k citations indexed

About

Jon Read is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Jon Read has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Jon Read's work include Melanoma and MAPK Pathways (4 papers), Cancer therapeutics and mechanisms (4 papers) and Axon Guidance and Neuronal Signaling (4 papers). Jon Read is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Cancer therapeutics and mechanisms (4 papers) and Axon Guidance and Neuronal Signaling (4 papers). Jon Read collaborates with scholars based in United Kingdom, United States and Singapore. Jon Read's co-authors include R.L. Brady, Richard B. Sessions, V.J. Winter, R. Tranter, David Carling, J. Breed, Dorin Toader, Catherine Bardelle, Jason G. Kettle and Huawei Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jon Read

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Read United Kingdom 25 1.3k 369 236 227 199 40 2.1k
Ganesha Rai United States 26 1.3k 1.0× 311 0.8× 142 0.6× 163 0.7× 175 0.9× 90 2.2k
Xing Du China 22 1.5k 1.1× 193 0.5× 343 1.5× 301 1.3× 278 1.4× 47 2.7k
Adam Yasgar United States 25 1.4k 1.1× 271 0.7× 186 0.8× 540 2.4× 286 1.4× 51 2.4k
Nam Doo Kim South Korea 32 1.8k 1.4× 454 1.2× 277 1.2× 230 1.0× 384 1.9× 102 2.9k
Jean‐Pierre Falgueyret Canada 32 1.4k 1.0× 960 2.6× 312 1.3× 114 0.5× 295 1.5× 73 3.0k
Robert X. Xu United States 22 1.5k 1.1× 251 0.7× 115 0.5× 111 0.5× 339 1.7× 30 2.3k
Tove Tuntland United States 25 732 0.6× 482 1.3× 124 0.5× 126 0.6× 214 1.1× 39 1.7k
Marina Ignatushchenko United States 9 1.9k 1.4× 304 0.8× 206 0.9× 304 1.3× 440 2.2× 10 2.9k
Maryanne Covington United States 28 912 0.7× 611 1.7× 355 1.5× 134 0.6× 585 2.9× 68 2.7k
Eugene L. Stewart United States 20 870 0.7× 377 1.0× 97 0.4× 183 0.8× 229 1.2× 47 2.2k

Countries citing papers authored by Jon Read

Since Specialization
Citations

This map shows the geographic impact of Jon Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Read more than expected).

Fields of papers citing papers by Jon Read

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Read. The network helps show where Jon Read may publish in the future.

Co-authorship network of co-authors of Jon Read

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Read. A scholar is included among the top collaborators of Jon Read based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Read. Jon Read is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collie, Gavin W., Matthew Clark, Anthony D. Keefe, et al.. (2024). Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity. Journal of Medicinal Chemistry. 67(2). 864–884. 15 indexed citations
2.
Bustraan, Sophia, Chad Whilding, Betheney R. Pennycook, et al.. (2024). AMP-activated protein kinase activation suppresses leptin expression independently of adipogenesis in primary murine adipocytes. Biochemical Journal. 481(5). 345–362. 5 indexed citations
3.
Holdgate, Geoffrey A., Catherine Bardelle, Jon Read, et al.. (2021). Drug discovery for epigenetics targets. Drug Discovery Today. 27(4). 1088–1098. 22 indexed citations
4.
Barlaam, Bernard, Scott Boiko, Scott Boyd, et al.. (2020). Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(22). 127523–127523. 3 indexed citations
5.
Read, Jon, Jonathan Tart, Philip B. Rawlins, et al.. (2019). Rapid Identification of Novel Allosteric PRC2 Inhibitors. ACS Chemical Biology. 14(10). 2134–2140. 9 indexed citations
6.
Read, Jon, Iain T. Collie, Michelle Nguyen-McCarty, et al.. (2019). Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase. Bioorganic & Medicinal Chemistry Letters. 29(15). 1962–1967. 7 indexed citations
7.
Navaratnam, Naveenan, et al.. (2017). Effect of different γ-subunit isoforms on the regulation of AMPK. Biochemical Journal. 474(10). 1741–1754. 49 indexed citations
8.
Biśta, Michał, Matthew D. Newton, Anne U. Goeppert, et al.. (2017). Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease. Nature Communications. 8(1). 1610–1610. 54 indexed citations
9.
Shirude, Pravin S., Prashanti Madhavapeddi, Maruti Naik, et al.. (2013). Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis. Journal of Medicinal Chemistry. 56(21). 8533–8542. 85 indexed citations
10.
Dakin, Les A., M. Block, Huawei Chen, et al.. (2012). Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases. Bioorganic & Medicinal Chemistry Letters. 22(14). 4599–4604. 85 indexed citations
11.
Wu, Jiaquan, Francoise Powell, Nicholas Larsen, et al.. (2012). Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol. ACS Chemical Biology. 8(3). 643–650. 118 indexed citations
12.
Bailey, David, Elisabeth P. Carpenter, Alun R. Coker, et al.. (2012). An analysis of subdomain orientation, conformational change and disorder in relation to crystal packing of aspartic proteinases. Acta Crystallographica Section D Biological Crystallography. 68(5). 541–552. 5 indexed citations
13.
Bardelle, Catherine, Bernard Barlaam, Nigel Brooks, et al.. (2010). Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(21). 6242–6245. 30 indexed citations
14.
Black, Emma, J. Breed, Alexander L. Breeze, et al.. (2005). Structure-based design of protein tyrosine phosphatase-1B inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(10). 2503–2507. 60 indexed citations
15.
Sullivan, Jane E., Geoffrey A. Holdgate, Douglas A. Campbell, et al.. (2005). Prevention of MKK6-Dependent Activation by Binding to p38α MAP Kinase. Biochemistry. 44(50). 16475–16490. 75 indexed citations
16.
Conners, Rebecca, Jon Read, Angus Cameron, et al.. (2005). Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase. Molecular and Biochemical Parasitology. 142(2). 137–148. 56 indexed citations
17.
Read, Jon, Richard B. Sessions, & R.L. Brady. (2000). Reply. Parasitology Today. 16(3). 133–133. 1 indexed citations
18.
Tranter, R., Jon Read, Roy Jones, & R.L. Brady. (2000). Effector Sites in the Three-Dimensional Structure of Mammalian Sperm β-Acrosin. Structure. 8(11). 1179–1188. 34 indexed citations
19.
Read, Jon, et al.. (1999). Chloroquine Binds in the Cofactor Binding Site ofPlasmodium falciparum Lactate Dehydrogenase. Journal of Biological Chemistry. 274(15). 10213–10218. 91 indexed citations
20.
Shoulders, Carol C., et al.. (1995). Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.. PubMed. 57(6). 1298–310. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ganesha Rai Breakdown of academic impact, for papers by Xing Du Breakdown of academic impact, for papers by Adam Yasgar Breakdown of academic impact, for papers by Nam Doo Kim Breakdown of academic impact, for papers by Jean‐Pierre Falgueyret Breakdown of academic impact, for papers by Robert X. Xu Breakdown of academic impact, for papers by Tove Tuntland Breakdown of academic impact, for papers by Marina Ignatushchenko Breakdown of academic impact, for papers by Maryanne Covington Breakdown of academic impact, for papers by Eugene L. Stewart
Rankless by CCL
2026